ArticleCell systems2026
Phased fragility and stability of non-genetic B cell states in the germinal center accelerate the genetic evolution of antibodies.
Article in Cell systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
Vaccine responses depend on the Darwinian genetic evolution of B cells to generate high-affinity antibodies. However, B cells gain non-genetic heterogeneity while searching for antigen and T helper cells, but then their non-genetic cell states remain stable within proliferative clonal bursts. We explored the functional consequence of this dynamic control of non-genetic variability by developing a mathematical model, integrating a wealth of immunological knowledge. We discovered that variability in B cell fate decisions does not impair but instead accelerates affinity maturation by allowing high-affinity outliers to escape plasma cell differentiation and seed further rounds of Darwinian evolution. During clonal bursts, non-genetic cell state stability further promotes their amplification. The resulting model correctly predicts emergent vaccine response properties in mouse strains with altered B cell fate decision profiles. Our work reconciles classical B cell clonal selection theory with the experimentally observed non-genetic variability, and it provides an interpretable knowledge-based modeling framework to support personalized vaccination strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.